Activity cliffs: Facts or artifacts?

Chemical Biology and Drug Design

Volumn 81, Issue 5, 2013, Pages 553-556

  Medina Franco, José L ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFACT; AWARENESS; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; DRUG ACTIVITY; DRUG DEVELOPMENT; DRUG POTENCY; DRUG SYNTHESIS; EDITORIAL; MOLECULAR MODEL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

COMPUTER SIMULATION; DRUG DISCOVERY; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84876875741     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12115     Document Type: Editorial

References (20)

1. Maggiora G.M. (2006) On outliers and activity cliffs-why QSAR often disappoints. J Chem Inf Model;46:1535.
2. Guha R. (2012) Exploring uncharted territories: Predicting activity cliffs in structure-activity landscapes. J Chem Inf Model;52:2181-2191.
3. Heikamp K., Hu X., Yan A., Bajorath J. (2012) Prediction of activity cliffs using support vector machines. J Chem Inf Model;52:2354-2365.
4. Stumpfe D., Bajorath J. (2012) Exploring activity cliffs in medicinal chemistry. J Med Chem;55:2932-2942.
5. Bajorath J. (2012) Modeling of activity landscapes for drug discovery. Expert Opin Drug Discov;7:463-473.
6. Guha R. (2012) Exploring structure-activity data using the landscape paradigm. Wiley Interdiscip Rev: Comput Mol Sci;2:829-841.
7. Wassermann A.M., Dimova D., Bajorath J. (2011) Comprehensive analysis of single- and multi-target activity cliffs formed by currently available bioactive compounds. Chem Biol Drug Des;78:224-228.
8. Faller B., Ottaviani G., Ertl P., Berellini G., Collis A. (2011) Evolution of the physicochemical properties of marketed drugs: Can history foretell the future? Drug Discovery Today;16:976-984.
9. Ganesan A. (2008) The impact of natural products upon modern drug discovery. Curr Opin Chem Biol;12:306-317.
10. Peltason L., Iyer P., Bajorath J. (2010) Rationalizing three-dimensional activity landscapes and the influence of molecular representations on landscape topology and the formation of activity cliffs. J Chem Inf Model;50:1021-1033.
11. Pérez-Villanueva J., Santos R., Hernández-Campos A., Giulianotti M.A., Castillo R., Medina-Franco J.L. (2010) Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg Med Chem;18:7380-7391.
12. Yongye A.B., Medina-Franco J.L. (2012) Data mining of protein-binding profiling data identifies structural modifications that distinguish selective and promiscuous compounds. J Chem Inf Model;52:2454-2461.
13. Hu Y., Bajorath J. (2012) Exploration of 3D activity cliffs on the basis of compound binding modes and comparison of 2D and 3D cliffs. J Chem Inf Model;52:670-677.
14. Medina-Franco J.L., Martínez-Mayorga K., Bender A., Marín R.M., Giulianotti M.A., Pinilla C., Houghten R.A. (2009) Characterization of activity landscapes using 2D and 3D similarity methods: Consensus activity cliffs. J Chem Inf Model;49:477-491.
15. Hu X., Hu Y., Vogt M., Stumpfe D., Bajorath J. (2012) MMP-cliffs: Systematic identification of activity cliffs on the basis of matched molecular pairs. J Chem Inf Model;52:1138-1145.
16. Agrafiotis D.K., Wiener J.J.M., Skalkin A., Kolpak J. (2011) Single R-group polymorphisms (SRPs) and R-cliffs: An intuitive framework for analyzing and visualizing activity cliffs in a single analog series. J Chem Inf Model;51:1122-1131.
17. Méndez-Lucio O., Pérez-Villanueva J., Castillo R., Medina-Franco J.L. (2012) Identifying activity cliff generators of PPAR ligands using SAS Maps. Mol Inf;31:837-846.
18. Nguyen K.T., Blum L.C., van Deursen R., Reymond J.-L. (2009) Classification of organic molecules by molecular quantum numbers. ChemMedChem;4:1803-1805.
19. Rabal O., Oyarzabal J. (2012) Using novel descriptor accounting for ligand-receptor interactions to define and visually explore the biologically relevant chemical space. J Chem Inf Model;52:1086-1102.
20. López-Vallejo F., Giulianotti M.A., Houghten R.A., Medina-Franco J.L. (2012) Expanding the medicinally relevant chemical space with compound libraries. Drug Discovery Today;17:718-726.